Nanotechnology-based antiviral therapeutics
Nanotechnology has emerged as one of the most promising technologies on account of its ability to deal with viral diseases
Category: Pharma applications
Antiviral Viroblock masks modified by CD from Wacker
Innovation in Textiles reported on the new masks of Swiss textile innovator HeiQ. The new mask, HeiQ Viroblock NPJ03 was
Biodegradable β ‐Cyclodextrin Conjugated Gelatin Methacryloyl Microneedle for Delivery of Water‐Insoluble Drug
Transdermal drug delivery offers advantages over nonparenteral routes such as bypassing first-pass metabolism and facile administration. Mammalian skin, however, functions
The Lord of the NanoRings: cyclodextrins and the battle against SARSCoV-2
Making a comparison between CDs and the unique Ring of the legendary novel of The Lord of the Rings, J.
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury® (Remdesivir) for the Treatment of COVID-19
Gilead Sciences, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration
Pfizer agrees to manufacture Gilead’s coronavirus drug remdesivir
Pfizer has agreed to manufacture and supply Gilead Sciences’ antiviral drug remdesivir, the pharmaceutical giant announced Friday. The multiyear agreement will support efforts to
Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems
This article reviews the controlled release of current anticancer drugs based on cyclodextrins as a “flexible switch”, and discusses the
Investigation of Cytotoxicity and Cell Uptake of Cationic Beta-Cyclodextrins as Valid Tools in Nasal Delivery
Cyclodextrin polymers have high applicability in pharmaceutical formulations due to better biocompatibility, solubility enhancement, loading capacity and controlled drug release
Breakthrough Therapy Designation Granted for SBECD-enabled Pevonedistat
Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for its SBECD
European Commission secures EU access to Remdesivir for treatment of COVID-19
The European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand